New research from Washington University School of Medicine in St. Louis indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients, and that the itching often doesn t respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don t target.
IDSA Foundation Announces More Than $1 Million in Grant Funds for Researchers Linking Infectious Agents in Alzheimerâs Disease
Newswise ARLINGTON, Va. (January 12, 2021) – Ten researchers who are exploring the link between an infectious agent and Alzheimer’s disease have each been awarded $100,000 research grants through the IDSA Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program. Since the program was established in 2018, the IDSA Foundation has provided more than $600,000 to seven researchers, making the 2020 awardees the largest recipient pool to date. The program will provide an additional pilot grant of $8,000 to begin research and initial data collection for a dementia study in Uganda.
Pollen Not Only Affects The Lungs But Can Trigger Pelvic Pain - Research Published January 11th, 2021 - 11:46 GMT
(Shutterstock/ File Photo)
Most folks are familiar with the havoc that high pollen levels can wreak on their lungs, but new research suggests they can also exacerbate a painful pelvic condition in some people. Our study provides evidence to suggest increased pollen counts may trigger symptom flares in people living with UCPPS [urologic chronic pelvic pain syndrome], said researcher Siobhan Sutcliffe, of Washington University School of Medicine in St. Louis. If the association with pollen levels is confirmed through future studies, it may help us to understand how flares occur in individuals with urologic chronic pelvic pain, as well as how to prevent or treat these otherwise unpredictable attacks, she added.
Written by Ginger Vieira on January 12, 2021 â Fact checked by Maria Gifford
Dr. Denise Faustman. Photo by Rick Friedman/Getty Images
Denise Faustman, MD, PhD, is known in many circles as one of the most controversial figures in type 1 diabetes (T1D) cure research. Sheâs raised millions of dollars and waves of hope with her work but has also been effectively shunned by the research community. Yet she barrels forward with her innovative vaccine-based approach to a cure, never letting naysayers deter her.
This is her story.
Motivated as a child
Born in Royal Oak, Michigan, Dr. Faustman now leads the Immunobiology Laboratory at Massachusetts General Hospital (MGH) and Harvard Medical School in Boston.